86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details


臨床試験数 : 1,205 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02587325
(ClinicalTrials.gov)
April 1, 201723/10/2015Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial HypertensionA Phase 1/1b Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension (PAH)Pulmonary HypertensionDrug: nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)Aadi Bioscience, Inc.NULLCompleted18 YearsN/AAll15Phase 1United States